Issue 40, 2020

Correction: In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

Abstract

Correction for ‘In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling’ by Thamer A. Alsubi et al., RSC Adv., 2020, 10, 22668–22683, DOI: 10.1039/D0RA01624A.

Associated articles

Article information

Article type
Correction
Submitted
17 Jun 2020
Accepted
17 Jun 2020
First published
23 Jun 2020
This article is Open Access
Creative Commons BY license

RSC Adv., 2020,10, 23930-23930

Correction: In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

T. A. Alsubi, M. W. Attwa, A. H. Bakheit, H. W. Darwish, H. A. Abuelizz and A. A. Kadi, RSC Adv., 2020, 10, 23930 DOI: 10.1039/D0RA90070B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements